Page 289 - FINAL PROGRAMME 2017

P-610 National reference materials of preimplantation genetic aneuploid screening based on next generation sequencing
J. Huang1, P. Liu2, F. Chen2, H. Jiang2, Y. Qiu2, D.Y. Chen2, J. Xia2, L. Xie2, Z. Zhu2, Q.Y. Shi2
1National Institutes for Food and Drug Control, National Institutes for Food and Drug Control, Beijing, China
2BGI-ShenZhen, R&D, ShenZhen, China
P-611 Does blastocyst biopsy technique effect aneuploidy rates?
J.B. Whitney1, R. Anderson2, C. Rios3, N. Nugent1, S. Zozula1, F. Garner4, M.C. Schiewe1 1Ovation Fertility, ART Lab, Newport Beach- CA, U.S.A.
2Southern California Center for Reproductive Medicine, Clinic, Newport Beach- CA, U.S.A. 3Ovation Genetics, Genetics Lab, Henderson- NV, U.S.A.
4Fertility Center of Las Vegas, Research, Las Vegas- NV, U.S.A.
P-612 Lessons learned from over 1,100 preimplantation genetic screening (PGS) cycles: blastocyst development and aneuploidy outcome analysis
R. Anderson1, J.B. Whitney2, M.C. Schiewe2
1Southern California Center for Reproductive Medicine, ART Lab, Newport Beach- CA, U.S.A. 2Ovation Fertility, ART Lab, Newport Beach- CA, U.S.A.
P-613 Advanced maternal age (AMA) and preimplantation genetic screening (PGS) outcome after FET – controlled retrospective study
D. Lorenzi1, M. Bilinski1, A. Quinteiro Retamar1, F. Nodar1, S. Kopelman1, S. Papier1, C. Alvarez Sedo1
1CEGYR Reproductive Medicine and Genetics, Reproductive Biology and Genetics, Buenos Aires, Argentina
P-614 Preimplantation genetic diagnosis (PGD): the number of matures oocytes is determinant for Reciprocal but not for Robertsonian translocations
A. Mayeur1, L. Hesters2, N. Ahdad3, S. Brisset4, J. Steffan5, G. Tachdjian4, S. Romana6, N. Achour-Frydman2
1Antoine Béclère Hospital, Unit of Reproductive Biology, Clamart, France 2Antoine Béclère Hospital, Unit of Reproductive Biology, Clamart, France 3Antoine Béclère Hospital, Unit of Reproductive Medicine, Clamart, France 4Antoine Béclère Hospital, Unit of Cytogenetic, Clamart, France 5Necker-Enfants Malades Hospital, Unit of Genetic, Paris, France 6Necker-Enfants Malades Hospital, Unit of Cytogenetic, Paris, France
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 289
POSTERS